Table 11.
Cells/tissues | Effects | Reference |
---|---|---|
VSMCs |
Nrf2-ARE signaling pathway, activation of NQO1. |
Hur et al., 2010 [71] |
| ||
H-monDC | Supress activation of PPARγ nuclear translocation, expression of CD40, CD86, CD1a, and HLA-DR, expression of IL-12 and IL-10, production of TNF-α, regulation of TLR4, myeloid differentiation of primary reactive protein 88, p38-MAPK signaling pathway. |
Sun et al., 2011 [72] |
| ||
Macrophage | Reduce mLDL uptake, antagonize CD36. |
Bao et al., 2012 [73] |
| ||
HASMCs | MMPs protein synthesis, downregulate ERK1/2, downregulate c-JNK. |
Lin et al., 2007 [74] |
Note: H-monDC: human monocyte-derived dendritic cells; Nrf2: nuclear factor 2-related factor 2; NQO1: NAD(P)H quinine oxidoreductase-1; PARP: poly ADP-ribose polymerase; ARE: antioxidant responsive element; VSMC: vascular smooth muscle cells; IL: interleukin; TLR: toll like receptor; TNF: tumor necrosis factor.